Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres.

Barry, A L

Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres. [electronic resource] - The Journal of antimicrobial chemotherapy Nov 1998 - 651-5 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0305-7453

10.1093/jac/42.5.651 doi


Academic Medical Centers
Anti-Bacterial Agents--pharmacology
Drug Resistance, Microbial
Enterococcus--drug effects
Erythromycin--pharmacology
Gram-Positive Bacterial Infections--microbiology
Gram-Positive Cocci--drug effects
Humans
Microbial Sensitivity Tests
North America
Staphylococcus--drug effects
Streptococcus--drug effects
Virginiamycin--pharmacology